Cormorant Asset Management, LP

13F Holdings History for Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP)

Symbol: RAPP on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value per share
Latest Disclosed Ownership: 3.19M shares
Security Ownership: 6.7%

Shares, Excluding Options vs Price

Value, Excluding Options

Cormorant Asset Management, LP ownership in Rapport Therapeutics, Inc. Common Stock, $0.001 par value per share (RAPP)

2025-11-14 - Cormorant Asset Management, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.19M shares of Rapport Therapeutics, Inc. Common Stock, $0.001 par value per share (RAPP). This represents 6.7% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Cormorant Asset Management, LP	6.7%		$94.8M	3.19M			$29.70	13G/A	9/30/2025	14 Nov 2025 13:09:26

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	6.54%	+0.52%	$94.8M	3.19M	+251,600	+8.56%	$29.70	Q3 2025
6/30/2025	2.49%		$33.4M	2.94M			$11.37	Q2 2025
3/31/2025	2.23%		$29.5M	2.94M			$10.03	Q1 2025
12/31/2024	2.87%		$52.2M	2.94M			$17.74	Q4 2024
9/30/2024	3.19%	+0%	$60.2M	2.94M	+638	+0.02%	$20.48	Q3 2024
6/30/2024	3.98%	+3.36%	$68.4M	2.94M	+2,940,283	NEW	$23.26	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.